410 related articles for article (PubMed ID: 7540486)
1. How useful are tests for rheumatoid factors, antiperinuclear factors, antikeratin antibody, and the HLA DR4 antigen for the diagnosis of rheumatoid arthritis?
Saraux A; Valls I; Voisin V; Koreichi A; Baron D; Youinou P; Le Goff P
Rev Rhum Engl Ed; 1995 Jan; 62(1):16-20. PubMed ID: 7540486
[TBL] [Abstract][Full Text] [Related]
2. Rheumatoid factor and antikeratin antibody are independent from presence of DR4 or DR1 in rheumatoid arthritis.
Cantagrel A; Constantin A; Vincent C; Abbal M; Laroche M; Ohayon E; Serre G; Mazières B
Rev Rhum Engl Ed; 1999 Jan; 66(1):20-3. PubMed ID: 10036694
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis.
Zeng X; Ai M; Tian X; Gan X; Shi Y; Song Q; Tang F
J Rheumatol; 2003 Jul; 30(7):1451-5. PubMed ID: 12858440
[TBL] [Abstract][Full Text] [Related]
4. Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process.
Aho K; von Essen R; Kurki P; Palosuo T; Heliövaara M
J Rheumatol; 1993 Aug; 20(8):1278-81. PubMed ID: 7693940
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of antikeratin antibodies in rheumatoid arthritis.
Ordeig J; Guardia J
J Rheumatol; 1984 Oct; 11(5):602-4. PubMed ID: 6210364
[TBL] [Abstract][Full Text] [Related]
6. HLA-DR4 antigen and IgM rheumatoid factors.
Queirós MV; Sancho MR; Caetano JM
J Rheumatol; 1982; 9(3):370-3. PubMed ID: 6981703
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value for rheumatoid arthritis of antiperinuclear factor at the 1:100 threshold. Study of 600 patients and meta-analysis of the literature.
Berthelot JM; Garnier P; Glémarec J; Flipo RM
Rev Rhum Engl Ed; 1998 Jan; 65(1):9-14. PubMed ID: 9523380
[TBL] [Abstract][Full Text] [Related]
8. Significance of antikeratin antibodies in rheumatoid arthritis.
Hajiroussou VJ; Skingle J; Gillett AP; Webley M
J Rheumatol; 1985 Feb; 12(1):57-9. PubMed ID: 2580092
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of anti-RA33 antibody, antikeratin antibody, antiperinuclear factor and antinuclear antibody in early rheumatoid arthritis: comparison with rheumatoid factor.
Cordonnier C; Meyer O; Palazzo E; de Bandt M; Elias A; Nicaise P; Haïm T; Kahn MF; Chatellier G
Br J Rheumatol; 1996 Jul; 35(7):620-4. PubMed ID: 8670593
[TBL] [Abstract][Full Text] [Related]
10. Antikeratin antibodies: diagnostic and prognostic markers for early rheumatoid arthritis.
Paimela L; Gripenberg M; Kurki P; Leirisalo-Repo M
Ann Rheum Dis; 1992 Jun; 51(6):743-6. PubMed ID: 1377463
[TBL] [Abstract][Full Text] [Related]
11. Immunogenetic heterogeneity of seronegative rheumatoid arthritis and the antiperinuclear factor.
Boerbooms AM; Westgeest AA; Reekers P; van de Putte LB
Ann Rheum Dis; 1990 Jan; 49(1):15-7. PubMed ID: 2310221
[TBL] [Abstract][Full Text] [Related]
12. [Relation between antiperinuclear factors, anti-keratin antibodies and the agglutinating and non-agglutinating rheumatoid factor in chronic polyarthritis].
Youinou P; Le Goff P; Miossec P; Moineau MP; Ferec C
Z Rheumatol; 1983; 42(1):36-9. PubMed ID: 6189305
[No Abstract] [Full Text] [Related]
13. Value of antibodies to citrulline-containing peptides for diagnosing early rheumatoid arthritis.
Saraux A; Berthelot JM; Devauchelle V; Bendaoud B; Chalès G; Le Henaff C; Thorel JB; Hoang S; Jousse S; Baron D; Le Goff P; Youinou P
J Rheumatol; 2003 Dec; 30(12):2535-9. PubMed ID: 14719190
[TBL] [Abstract][Full Text] [Related]
14. Adult seronegative arthritis with antinuclear antibodies: a distinct group of patients with a different immunogenetic pattern from seropositive rheumatoid arthritis and a good outcome.
Saudan-Kister A; Gabay C; Tiercy JM; Mermillod B; Guerne PA; Vischer TL
Rev Rhum Engl Ed; 1996 May; 63(5):313-20. PubMed ID: 8789876
[TBL] [Abstract][Full Text] [Related]
15. Rheumatoid arthritis in a Chippewa band. II. Field study with clinical serologic and HLA-D correlations.
Harvey J; Lotze M; Arnett FC; Bias WB; Billingsley LM; Harvey E; Hsu SH; Sutton JD; Zizic TM; Stevens MB
J Rheumatol; 1983 Feb; 10(1):28-32. PubMed ID: 6601712
[TBL] [Abstract][Full Text] [Related]
16. Prospect for an additional laboratory criterion for rheumatoid arthritis.
von Essen R; Kurki P; Isomäki H; Okubo S; Kautiainen H; Aho K
Scand J Rheumatol; 1993; 22(6):267-72. PubMed ID: 7505480
[TBL] [Abstract][Full Text] [Related]
17. Antiperinuclear factor: indicator of more severe disease in seronegative rheumatoid arthritis.
Westgeest AA; Boerbooms AM; Jongmans M; Vandenbroucke JP; Vierwinden G; van de Putte LB
J Rheumatol; 1987 Oct; 14(5):893-7. PubMed ID: 3501470
[TBL] [Abstract][Full Text] [Related]
18. Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis.
Kapitány A; Szabó Z; Lakos G; Aleksza M; Végvári A; Soós L; Karányi Z; Sipka S; Szegedi G; Szekanecz Z
Isr Med Assoc J; 2008 Jan; 10(1):32-6. PubMed ID: 18300568
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic significance of the antiperinuclear factor for rheumatoid arthritis.
Janssens X; Veys EM; Verbruggen G; Declercq L
J Rheumatol; 1988 Sep; 15(9):1346-50. PubMed ID: 3058971
[TBL] [Abstract][Full Text] [Related]
20. [Comparative characteristics of specific autoantibodies in rheumatoid arthritis].
Lapin SV; Maslianskiĭ AL; Mazurov VI; Totolian AA
Ter Arkh; 2005; 77(12):53-9. PubMed ID: 16514821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
